Key facts
| Price (PPV) | 4,395 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | sofosbuvirvelpatasvir |
| Class | Antivirals for systemic use |
| ATC code | J05AP55 |
| Manufacturer | VIATRIS PHARMACEUTICALS |
| Presentation | Boite de 28 |
| Hospital price | 4,112 MAD |
| Data collected on | 9/8/2026 |
Indications
Epclusa est indiqué pour le traitement de l’infection chronique par le virus de l’hépatite C (VHC) chez les adultes
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
One other product contains the same active substance as Myhep All 400 mg / 100 mg (Sofosbuvir | Velpatasvir), at the same strength and in the same dosage form. The prices below are per pack: compare pack sizes before comparing prices.
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Epclusa 400 mg / 100 mg | AFRIC-PHAR | Boite de 28 | 6,100 MAD | 217.86 / unit | — |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Myhep All 400 mg / 100 mg
Myhep All 400 mg / 100 mg belongs to the antivirals for systemic use therapeutic class. In Morocco, this drug is marketed by VIATRIS PHARMACEUTICALS and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Myhep All 400 mg / 100 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Myhep All 400 mg / 100 mg
Answers to common questions from Moroccan patients about this drug.